February 21, 2023
The University of Cincinnati's Caleb Adler spoke with Local 12 about effective treatments for clinical depression in light of Senator John Fetterman announcing he is being treated for clinical depression.
June 15, 2022
The University of Cincinnati's Paul Crosby, MD, was a guest on Local 12's What's Happening in Health program to discuss the ongoing mental health crisis and the Lindner Center of HOPE's new campaign to expand services.
August 30, 2022
The Guardian featured University of Cincinnati researcher Erica Birkley in an article on the effect of Americans halting COVID precautions on vulnerable populations.
March 28, 2023
The University of Cincinnati's Jeffrey Strawn was featured in a PsyCom Pro article highlighting new research that found ADHD treatments may also help executive function deficits.
May 23, 2023
The University of Cincinnati's Steven Kniffley Jr., PsyD, was featured in an Associated Press article discussing how racism affects the mental health of Black children.
September 13, 2023
Baton Rouge television station WAFB highlighted recent University of Cincinnati research led by Jeffrey Strawn, MD, that found in utero exposure to certain flame retardant chemicals may be a risk factor for developing anxiety symptoms in early adolescence.
December 1, 2023
The University of Cincinnati's LaTrice Montgomery joined WVXU's Cincinnati Edition to discuss the potential health benefits and harms associated with expanded cannabis access after Ohio voters approved legalizing recreational marijuana in the November election.
February 26, 2024
The University of Cincinnati's Susan McElroy, MD, spoke with CNN about the impact weight loss medications like semaglutide have on people with eating disorders.
June 27, 2024
The University of Cincinnati's John Winhusen and Caroline Freiermuth discussed the evidence-based practices implemented during the HEALing Communities Study to fight the opioid epidemic with Spectrum News.
February 6, 2024
A new University of Cincinnati trial, in partnership with Spark Biomedical, will test a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.